Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.60 | €130.00 | 6.036% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.00 | €124.92 | 4.977% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.77 | €15.58 | -1.198% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.11 | €116.81 | 21.535% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.23 | €40.66 | 55.041% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.74 | €78.42 | 48.696% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.90 | €196.74 | 40.626% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.28 | €174.43 | 16.850% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | €910.40 | €959.41 | 5.384% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.52 | €86.77 | 38.789% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.06 | €200.06 | 28.193% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €287.80 | €297.31 | 3.305% |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €706.00 | €766.92 | 8.629% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €209.70 | €294.01 | 40.205% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €396.05 | €408.36 | 3.108% |